Citation Impact
Citing Papers
A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
1997
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults
2007
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
1999 Standout
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment
2015 Standout
Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors
1992
Mechanisms of Thrombus Formation
2008 Standout
Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis
1992
Intracerebral haemorrhage
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
1992
Blood pressure during the first minutes of focal cerebral ischemia
1993
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy
1993
A new regimen for heparin use in acute coronary syndromes
1999
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old
1996
Antithrombotic Therapy for Coronary Artery Disease
2004
Determination of a weight-adjusted dose of TNK–tissue plasminogen activator
2001
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
1999 Standout
Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.
1997
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial
1999
Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage
2004
Surgical bleeding: unexpected effect of a calcium antagonist
1995
Antithrombotic Therapy for VTE Disease
2012 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction
1991
Stroke
2008 Standout
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction
1991
Diabetes and Atherosclerosis
2002 Standout
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes
2008
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2008 Standout
Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)
2003
Guidelines for Quality Assurance in Multicenter Trials
1998
Antithrombotic Therapy in Neonates and Children
2008
PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2
1992
Subarachnoid haemorrhage
2007 Standout
The Determinants of Activated Partial Thromboplastin Time, Relation of Activated Partial Thromboplastin Time to Clinical Outcomes, and Optimal Dosing Regimens for Heparin Treated Patients with Acute Coronary Syndromes: A Review of GUSTO-IIb
2002
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
The Pathobiology of Vascular Dementia
2013 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Conflict of Interest in the Debate over Calcium-Channel Antagonists
1998 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Intravenous Magnesium versus Nimodipine in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized Study
2006
Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
2002 Standout
Weight-based rt-PA Thrombolysis Protocol for Acute Native Arterial and Bypass Graft Occlusions
2002
Calcium antagonists for aneurysmal subarachnoid haemorrhage
2005
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)
1995
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
1995 Standout
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Reduced Dose Bolus Alteplase vs Conventional Alteplase Infusion for Pulmonary Embolism Thrombolysis
1994
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Stroke in Patients With Acute Coronary Syndromes
1999
Pulmonary Embolism: What have We Learned Since Virchow?
2002
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Intracranial Hemorrhage Associated With Thrombolytic Therapy for Elderly Patients With Acute Myocardial Infarction
2000
Acute stroke: evaluation and treatment.
2005
Hemorrhagic Transformation in Acute Ischemic Stroke
1999
Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum
2011
Trial Design and Reporting Standards for Intraarterial Cerebral Thrombolysis for Acute Ischemic Stroke
2003
A Community-Based Study of Stroke Incidence after Myocardial Infarction
2005
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Intravenous Alteplase for Stroke
2007
Should Dihydropyridines Be Used as First-Line Drugs in the Treatment of Hypertension?
1995
Hemorrhagic Transformation in Acute Ischemic Stroke
1997
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Coronary Thrombolysis for the Elderly?
1991
Warfarin-associated hemorrhage and cerebral amyloid angiopathy
2000
Nifedipine
1995 Standout
Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke
1996
Works of Anna Randall being referenced
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardial infarction
1996
Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction
1995
P48 Auditing and verification of clinical data: A coordinating center's role
1996
Intracranial hemorrhage after rt-pa and heparin for acute myocardial infarction — The TIMI II pilot and randomized trial combined experience
1990
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
1991